Drug intelligence / Profile preview

PeptiStrong

Development stage
Unknown
Lead developer
Nuritas
Modality
Peptides
Administration
Oral
01

Overview

PeptiStrong is a patented, plant-based peptide ingredient derived from the enzymatic hydrolysis of fava bean proteins, developed using artificial intelligence by Nuritas to support muscle health, strength, recovery, and endurance. Clinically studied, it consists of a network of bioactive cell-signaling peptides that stimulate muscle protein synthesis, suppress muscle breakdown, and modulate biomarkers related to blood sugar, bone health, and metabolism[1][4][6][7][8]. PeptiStrong is as effective as leucine at a fraction of the dose, outperforms HMB and creatine in several biomarker endpoints, and can quadruple the muscle protein synthesis effect compared to whey or milk proteins[1][2][3][8][9]. Its mechanisms include mTOR pathway upregulation and myostatin reduction, contributing to muscle anabolism and reduced loss during catabolic states, such as immobilization or rapid weight loss. It holds self-affirmed GRAS and Health Canada approvals[2][4][7]. PeptiStrong can be used as a dietary supplement or food ingredient and is optimized for bioavailability with demonstrated benefit for populations ranging from active adults to the elderly and those on weight-loss medications[3][4][9].

Brand names
PeptiStrong
Other names
PeptiStrong
02

Targets

GDF8 (Myostatin)mTOR (Mammalian target of rapamycin kinase)

Beyond the preview

Go deeper on PeptiStrong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PeptiStrong.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call